Quirin Hammer

15PUBLICATIONS
75CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursInnate immunityImmunogenetics (incl. genetic immunology)Creative arts, media and communication curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 13, 2026
Antibody S22019F Selectively Recognises KIR2DS1 and Enables Analysis of KIR2DS1+ NK Cells and T Cells.

|Jul 18, 2025
Tissue origin and virus specificity shape human CD8+ T cell cytotoxicity.

Julia Niessl, Thomas R Müller, Christian Constantz

|Dec 09, 2024
Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness.

Eleni Bilev, Nicole Wild, Pouria Momayyezi

|Nov 02, 2024
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19.

Benedikt Strunz, Pouria Momayyezi, Eleni Bilev

|Apr 24, 2024
Engineering immune-evasive allogeneic cellular immunotherapies.

Karen E Martin, Quirin Hammer, Karlo Perica

|Oct 24, 2023
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells.

Quirin Hammer, Karlo Perica, Hanna van Ooijen

Pageof 3

Frequent Collaborators

3 joint publications

Chiara Romagnani

3 joint publications

Marcus Buggert

3 joint publications

Karl-Johan Malmberg

3 joint publications

Johan K Sandberg